Hepion Pharmaceuticals's market cap is currently $2.00M. The company's EPS TTM is $-4.386; its P/E ratio is ―; Hepion Pharmaceuticals is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Gross Profit	$ -67.13K	$ -77.46K	$ -86.07K	$ -34.52K	$ -26.74K
Operating Income	$ -48.45M	$ -45.49M	$ -30.40M	$ -20.15M	$ -7.77M
EBITDA	$ -49.26M	$ -43.54M	$ -30.32M	$ -20.11M	$ -7.74M
Net Income	$ -48.93M	$ -42.20M	$ -32.72M	$ -20.35M	$ -7.04M
Balance Sheet
Cash & Short-Term Investments	$ 14.79M	$ 51.19M	$ 91.35M	$ 40.73M	$ 13.92M
Total Assets	$ 18.09M	$ 60.24M	$ 103.55M	$ 48.65M	$ 20.61M
Total Debt	$ 209.02K	$ 53.61K	$ 316.99K	$ 752.17K	$ 807.45K
Net Debt	$ -14.58M	$ -51.14M	$ -91.03M	$ -39.97M	$ -13.12M
Total Liabilities	$ 10.81M	$ 10.39M	$ 10.56M	$ 8.12M	$ 4.99M
Stockholders' Equity	$ 7.28M	$ 49.86M	$ 93.00M	$ 40.52M	$ 15.62M
Cash Flow
Free Cash Flow	$ -40.90M	$ -34.98M	$ -31.35M	$ -16.25M	$ -7.62M
Operating Cash Flow	$ -40.89M	$ -34.96M	$ -31.22M	$ -16.17M	$ -7.57M
Investing Cash Flow	$ -14.30K	$ -14.07K	$ -130.41K	$ -85.79K	$ -51.47K
Financing Cash Flow	$ 4.49M	$ -5.14M	$ 81.98M	$ 43.05M	$ 18.71M

Currency in USD

Hepion Pharmaceuticals Earnings and Revenue History

Income Statement >

Hepion Pharmaceuticals Debt to Assets

Balance Sheet >

Hepion Pharmaceuticals Cash Flow

Cash Flow >

Hepion Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing